The BioPharm Brief: Biomarkers, Bleeding, Breakthroughs

Jul 08, 06:55 PM
Headliner
Share
Subscribe

Today's BioPharm Brief highlights advances in neurology, hematology, and nephrology, featuring new Alzheimer's disease biomarker data, an expanded pediatric approval for von Willebrand disease prophylaxis, and the first dual BAFF and APRIL inhibitor approved for IgA nephropathy.

Share
Subscribe
Next
The BioPharm Brief: Smarter Targeting, Myeloid Engagers, Neuron Replacement
Top episodes
The BioPharm Brief: Early Design Risks, Oncology Signals, and a Biosimilars Power Move
by The BioPharm Brief
The BioPharm Brief: What’s the Big Deal About Multispecific T-Cell Engagers in Cancer and Autoimmune Diseases?
by The BioPharm Brief
The BioPharm Brief: Regulatory Shifts, Rare Disease Innovation, and Precision Drug Development Trends
by The BioPharm Brief